Inmed Pharmaceuticals Stock Technical Analysis
| INM Stock | USD 5.26 0.11 2.14% |
As of the 15th of December 2024, InMed Pharmaceuticals retains the risk adjusted performance of 0.0226, and Market Risk Adjusted Performance of (0.24). InMed Pharmaceuticals technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out InMed Pharmaceuticals coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and semi variance to decide if InMed Pharmaceuticals is priced fairly, providing market reflects its last-minute price of 5.26 per share. Given that InMed Pharmaceuticals has jensen alpha of 0.1627, we strongly advise you to confirm InMed Pharmaceuticals's regular market performance to make sure the company can sustain itself at a future point.
InMed Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as InMed, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to InMedInMed |
InMed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
InMed Pharmaceuticals Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of InMed Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
InMed Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for InMed Pharmaceuticals. You can use it to identify possible trend reversals for InMed Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual InMed Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.InMed Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for InMed Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0 , which may imply that InMed Pharmaceuticals will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 0.58, which is the sum of squared deviations for the predicted InMed Pharmaceuticals price change compared to its average price change.About InMed Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of InMed Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of InMed Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on InMed Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding InMed Pharmaceuticals. By analyzing InMed Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of InMed Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to InMed Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2022 | 2023 | 2024 (projected) | Graham Number | 18.99 | 5.26 | 208.7 | Receivables Turnover | 15.88 | 13.03 | 10.07 |
InMed Pharmaceuticals December 15, 2024 Technical Indicators
Most technical analysis of InMed help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for InMed from various momentum indicators to cycle indicators. When you analyze InMed charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0226 | |||
| Market Risk Adjusted Performance | (0.24) | |||
| Mean Deviation | 4.77 | |||
| Semi Deviation | 6.38 | |||
| Downside Deviation | 6.82 | |||
| Coefficient Of Variation | 5295.51 | |||
| Standard Deviation | 6.87 | |||
| Variance | 47.19 | |||
| Information Ratio | 0.0043 | |||
| Jensen Alpha | 0.1627 | |||
| Total Risk Alpha | (0.73) | |||
| Sortino Ratio | 0.0043 | |||
| Treynor Ratio | (0.25) | |||
| Maximum Drawdown | 39.14 | |||
| Value At Risk | (9.22) | |||
| Potential Upside | 10.0 | |||
| Downside Variance | 46.5 | |||
| Semi Variance | 40.73 | |||
| Expected Short fall | (5.05) | |||
| Skewness | 0.4134 | |||
| Kurtosis | 1.92 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InMed Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in InMed Stock, please use our How to Invest in InMed Pharmaceuticals guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InMed Pharmaceuticals. If investors know InMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InMed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 230.4 | Revenue Per Share 0.603 | Quarterly Revenue Growth (0.45) | Return On Assets (0.39) | Return On Equity (0.72) |
The market value of InMed Pharmaceuticals is measured differently than its book value, which is the value of InMed that is recorded on the company's balance sheet. Investors also form their own opinion of InMed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is InMed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InMed Pharmaceuticals' market value can be influenced by many factors that don't directly affect InMed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InMed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if InMed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InMed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.